Payment overview · 2025
General Payments
$1,931.84
5 reported records · 1 companies
Healthcare provider profile · identity verified
Timothy Howard Hatcher, PA-C
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical · NEW HAVEN, CT · NPI 1679501092
Verified facts
What the public records show
CMS Open Payments records show Timothy Howard Hatcher, PA-C received $1,931.84 in general payments during 2025 across 5 reported records.
INTUITIVE SURGICAL, INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $1,931.84 | 100.0% | 5 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,906.77 | 4 |
| Food and Beverage | $25.07 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $1,931.84 | 5 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 605 | 107 |
| Dovato | Dolutegravir Sodium/Lamivudine | 365 | 56 |
| Atorvastatin Calcium | Atorvastatin Calcium | 345 | 89 |
| Oxycodone Hcl | Oxycodone Hcl | 262 | 30 |
| Amlodipine Besylate | Amlodipine Besylate | 255 | 60 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 212 | 53 |
| Gabapentin | Gabapentin | 202 | 51 |
| Lisinopril | Lisinopril | 192 | 46 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 191 | 42 |
| Tivicay | Dolutegravir Sodium | 187 | 37 |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 172 | 32 |
| Trazodone Hcl | Trazodone Hcl | 165 | 28 |
| Juluca | Dolutegravir/Rilpivirine | 161 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 149 | 34 |
| Tramadol Hcl | Tramadol Hcl | 140 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 137 | 30 |
| Descovy | Emtricitabine/Tenofov Alafenam | 126 | 21 |
| Odefsey | Emtricitab/Rilpiviri/Tenof Ala | 123 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 117 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 30 |
| Montelukast Sodium | Montelukast Sodium | 105 | 16 |
| Losartan Potassium | Losartan Potassium | 99 | 29 |
| Ibuprofen | Ibuprofen | 95 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 94 | 23 |
| Valacyclovir | Valacyclovir Hcl | 94 | 26 |
| Levothyroxine Sodium | Levothyroxine Sodium | 91 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 87 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 81 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 74 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 72 | 27 |
| Bupropion Xl | Bupropion Hcl | 70 | 11 |
| Eliquis | Apixaban | 70 | 13 |
| Sertraline Hcl | Sertraline Hcl | 68 | 16 |
| Metformin Hcl | Metformin Hcl | 65 | 21 |
| Mirtazapine | Mirtazapine | 65 | 19 |
| Furosemide | Furosemide | 64 | 12 |
| Metformin Hcl Er | Metformin Hcl | 64 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | 11 |
| Famotidine | Famotidine | 57 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 53 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 53 | 16 |
| Prezcobix | Darunavir/Cobicistat | 52 | 11 |
| Carvedilol | Carvedilol | 51 | 15 |
| Ozempic | Semaglutide | 50 | 15 |
| Azithromycin | Azithromycin | 49 | 20 |
| Alendronate Sodium | Alendronate Sodium | 48 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 48 | suppressed |
| Darunavir | Darunavir | 48 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 13 |
| Fluconazole | Fluconazole | 46 | 12 |
| Ritonavir | Ritonavir | 45 | suppressed |
| Acyclovir | Acyclovir | 44 | suppressed |
| Amoxicillin | Amoxicillin | 44 | 17 |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 44 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 44 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 20 |
| Isentress | Raltegravir Potassium | 41 | suppressed |
| Pregabalin | Pregabalin | 40 | suppressed |
| Linzess | Linaclotide | 39 | suppressed |
| Meloxicam | Meloxicam | 38 | 12 |
| Omeprazole | Omeprazole | 38 | suppressed |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 38 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 37 | suppressed |
| Allopurinol | Allopurinol | 36 | suppressed |
| Levetiracetam | Levetiracetam | 36 | suppressed |
| Cefadroxil | Cefadroxil | 35 | suppressed |
| Loperamide | Loperamide Hcl | 35 | suppressed |
| Ondansetron Odt | Ondansetron | 35 | suppressed |
| Spironolactone | Spironolactone | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Pifeltro | Doravirine | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Cephalexin | Cephalexin | 31 | suppressed |
| Ketoconazole | Ketoconazole | 31 | suppressed |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Topiramate | Topiramate | 31 | suppressed |
| Abacavir-Lamivudine | Abacavir Sulfate/Lamivudine | 30 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 30 | suppressed |
| Rukobia | Fostemsavir Tromethamine | 30 | suppressed |
| Valsartan | Valsartan | 30 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 29 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 27 | suppressed |
| Selenium Sulfide | Selenium Sulfide | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Lamivudine | Lamivudine | 22 | suppressed |
| Nystatin | Nystatin | 22 | 12 |
| Colchicine | Colchicine | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 21 | suppressed |
| Jardiance | Empagliflozin | 21 | suppressed |
| Lactulose | Lactulose | 21 | suppressed |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 21 | suppressed |
| Ethambutol Hcl | Ethambutol Hcl | 20 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Testosterone | Testosterone | 20 | suppressed |
| Creon | Lipase/Protease/Amylase | 19 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 19 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 18 | suppressed |
| Edurant | Rilpivirine Hcl | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Ibu | Ibuprofen | 18 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Potassium Chloride | Potassium Chloride | 17 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Delstrigo | Doravirine/Lamivu/Tenofov Diso | 16 | suppressed |
| Efavirenz-Emtric-Tenofov Disop | Efavirenz/Emtricit/Tenofovr Df | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 11 |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Emtricitabine | Emtricitabine | 13 | suppressed |
| Estradiol Valerate | Estradiol Valerate | 13 | suppressed |
| Fluocinolone Acetonide Oil | Fluocinolone Acetonide Oil | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Tadalafil | Tadalafil | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Zidovudine | Zidovudine | 13 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Moxifloxacin Hcl | Moxifloxacin Hcl | 12 | suppressed |
| Abacavir | Abacavir Sulfate | 11 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fluocinonide-E | Fluocinonide/Emollient Base | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Lamivudine Hbv | Lamivudine | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Prednisone | Prednisone | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Terconazole | Terconazole | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,931.84 · 5 records | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error